SHALBY2023-10-012023-12-31 SHALBY2023-10-012023-12-31 SHALBY2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member SHALBY2023-10-012023-12-31in-bse-fin:OneOperatingExpenses02Member SHALBY2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member SHALBY2023-10-012023-12-31in-bse-fin:FourOperatingExpenses02Member SHALBY2023-12-31 SHALBY2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue01Member SHALBY2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue02Member SHALBY2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue01Member SHALBY2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue02Member SHALBY2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults01Member SHALBY2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults02Member SHALBY2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults01Member SHALBY2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults02Member SHALBY2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets01Member SHALBY2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets02Member SHALBY2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member SHALBY2023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member SHALBY2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member SHALBY2023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 540797 SHALBY NOTLISTED Shalby Limited Equity 2023-04-01 2024-03-31 2024-02-07 2024-01-30 INR Millions Third quarter 13:15:00 14:10:00 2024-02-07 2024-02-07 Not applicable Multi segment 2023-10-01 2023-12-31 Unaudited Consolidated 2160470000.00 45190000.00 2205660000.00 72700000.00 191280000.00 -113730000.00 377570000.00 36330000.00 124030000.00 1209370000.00 1897550000.00 308110000.00 0.00 308110000.00 147750000.00 -30280000.00 117470000.00 0.00 190640000.00 0.00 0.00 0.00 0.00 190640000.00 10000.00 190650000.00 190710000.00 -70000.00 20000.00 0.00 1073525000.00 10 1.78 1.78 0.00 0.00 1.78 1.78 Notes to the Unaudited Consolidated Financial Results for the Quarter and Nine months ended December 31, 2023 1.The above unaudited financial results for the quarter and Nine Month ended December 31, 2023 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the company at their respective meetings held on February 7 ,2024. The Statutory Auditors of the Company have carried out a Limited Review for said unaudited financial results. 2. These financial results have been prepared in accordance with Indian Accounting Standards (Ind- AS) as prescribed under section 133 of Companies Act 2013 read with Rule 3 of the Companies (Indian Accounting Standards) Rules 2015 and relevant amendment thereafter. 3.Shalby Limited Employees Welfare Trust has acquired 7,00,000 Equity Shares of Shalby Limited in June 2022 pursuant to Employee Stock Option Scheme-2021. During the quarter ended December 31, 2023, the Company has granted 6,000 Stock Options. Till December 31, 2023, Company has granted 2,93,235 Stock Options to eligible employees, out of which total 66,000 Stock Options were lapsed and 42,735 options were exercised. 4.The Company has acquired 87.26% stake in shareholding of PK Healthcare Private Limited, through preferential allotment of equity shares and secondary acquisition from promoters during January 2024. PK Healthcare Pvt. Ltd. is now a subsidiary of the Company. 5. During the quarter ended December 31, 2023, Mars Medical Devices Limited, wholly-owned subsidiary of the Company has invested 2,00,000 Preference Shares of the face value of SGD 10 (Singapore Dollar Ten only) in its subsidiary Shalby Global Technologies Pte. Ltd. at a price of SGD 10 (Singapore Dollar Ten only). 6. The consolidated financial result includes the results of the Company and 10 Subsidiary companies (Covering 2 stepdown subsidiaies). The company together with its subsidiaries is herein referred to as the Group . 7. The Company is not a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P /2018/144 dated 26th November, 2018. 8. The Code on Social Security, 2020 ('Code') relating to employee benefits during employment and post-employment benefits has received Presidential assent and has been published in the Gazette of India. However, the effective date of the Code and final rules for quantifying the financial impact are yet to be notified. The Group will assess the impact of the Code when relevant provisions are notified and will record related impact, if any, in the period the Code becomes effective. 9. As per Indian Accounting Standard ( Ind AS ) 108 - Segment Reporting , segment information has been provided in Consolidated Financial Results. The business segments of the company comprise of Healthcare Activities & Manufacturing of Implant. Disclosure for the same is given in the separate note. 10. Previous period figures have been re-grouped, re-cast and re-arranged wherever considered necessary to make it comparable. Multi segment 2023-04-01 2023-12-31 Unaudited Consolidated 6895160000.00 144370000.00 7039530000.00 241920000.00 585950000.00 -359200000.00 1155140000.00 95590000.00 366430000.00 3889580000.00 5975410000.00 1064120000.00 0.00 1064120000.00 478890000.00 -89360000.00 389530000.00 0.00 674590000.00 0.00 0.00 0.00 0.00 674590000.00 -980000.00 673610000.00 674770000.00 -200000.00 -960000.00 0.00 1073525000.00 10 6.28 6.28 0.00 0.00 6.28 6.28 Fees to Doctors and Consultants 495650000.00 Other Expenses 713720000.00 Fees to Doctors and Consultants 1521062000.00 Other Expenses 2368518000.00 Healthcare Services 1945222000.00 Manufacturing of Implants 215253000.00 Healthcare Services 6369941000.00 Manufacturing of Implants 525222000.00 2160475000.00 6895163000.00 2160475000.00 6895163000.00 Healthcare Services 370583000.00 Manufacturing of Implants -62480000.00 Healthcare Services 1229181000.00 Manufacturing of Implants -165069000.00 308103000.00 1064112000.00 0.00 0.00 0.00 0.00 308103000.00 1064112000.00 Healthcare Services 10925560000.00 Manufacturing of Implants 2775731000.00 13701291000.00 Healthcare Services -1300946000.00 Manufacturing of Implants -2569135000.00 -3870081000.00 990000.00 2960000.00 350000.00 1050000.00 630000.00 2890000.00